These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9591753)

  • 21. Lack of association between Alzheimer's disease and Gln-Arg 192 Q/R polymorphism of the PON-1 gene in an Italian population.
    Pola R; Gaetani E; Flex A; Gerardino L; Aloi F; Flore R; Serricchio M; Pola P; Bernabei R
    Dement Geriatr Cogn Disord; 2003; 15(2):88-91. PubMed ID: 12566597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipid peroxidation is increased in paraoxonase L55 homozygotes compared with M-allele carriers.
    Malin R; Laine S; Rantalaiho V; Wirta O; Pasternack A; Jokela H; Alho H; Koivula T; Lehtimäki T
    Free Radic Res; 2001 May; 34(5):477-84. PubMed ID: 11378531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paraoxonase (PON1) polymorphism & its relation with lipids in north west Indian Punjabis.
    Singh S; Verma M; Nain CK; Leelamma CO; Goel RC
    Indian J Med Res; 1999 Oct; 110():133-7. PubMed ID: 10645101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inverse correlation of serum paraoxonase and homocysteine thiolactonase activities and antioxidant capacity of high-density lipoprotein with the severity of cardiovascular disease in persons with type 2 diabetes mellitus.
    Lakshman MR; Gottipati CS; Narasimhan SJ; Munoz J; Marmillot P; Nylen ES
    Metabolism; 2006 Sep; 55(9):1201-6. PubMed ID: 16919539
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The paraoxonase Gln-Arg 192 polymorphism in patients with endogenous hypertriglyceridemia in Chinese population].
    Liu R; Bai H; Liu Y; Huang M; Fan P; Liu B
    Hua Xi Yi Ke Da Xue Xue Bao; 2002 Apr; 33(2):229-32. PubMed ID: 12575193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The paraoxonase-2-310 polymorphism is associated with the presence of microvascular complications in diabetes mellitus.
    Mackness B; McElduff P; Mackness MI
    J Intern Med; 2005 Oct; 258(4):363-8. PubMed ID: 16164576
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation between the activities of lipoprotein lipase and paraoxonase in type 2 diabetes mellitus.
    Kalmár T; Seres I; Balogh Z; Káplár M; Winkler G; Paragh G
    Diabetes Metab; 2005 Dec; 31(6):574-80. PubMed ID: 16357806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of insulin resistance on serum paraoxonase activity in a nondiabetic population.
    Yamada A; Shoji T; Tahara H; Emoto M; Nishizawa Y
    Metabolism; 2001 Jul; 50(7):805-11. PubMed ID: 11436186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LL-paraoxonase genotype is associated with a more severe degree of homeostasis model assessment IR in healthy subjects.
    Barbieri M; Bonafè M; Marfella R; Ragno E; Giugliano D; Franceschi C; Paolisso G
    J Clin Endocrinol Metab; 2002 Jan; 87(1):222-5. PubMed ID: 11788650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paraoxonase gene polymorphism in Japanese subjects with coronary heart disease.
    Suehiro T; Nakauchi Y; Yamamoto M; Arii K; Itoh H; Hamashige N; Hashimoto K
    Int J Cardiol; 1996 Nov; 57(1):69-73. PubMed ID: 8960946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Gln/Arg polymorphism of human paraoxonase (PON 192) is not related to myocardial infarction in the ECTIM Study.
    Herrmann SM; Blanc H; Poirier O; Arveiler D; Luc G; Evans A; Marques-Vidal P; Bard JM; Cambien F
    Atherosclerosis; 1996 Oct; 126(2):299-303. PubMed ID: 8902155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Promoter polymorphism T(-107)C of the paraoxonase PON1 gene is a risk factor for coronary heart disease in type 2 diabetic patients.
    James RW; Leviev I; Ruiz J; Passa P; Froguel P; Garin MC
    Diabetes; 2000 Aug; 49(8):1390-3. PubMed ID: 10923642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paraoxonase-1 (PON-1) genotype and activity and in vivo oxidized plasma low-density lipoprotein in Type II diabetes.
    Sampson MJ; Braschi S; Willis G; Astley SB
    Clin Sci (Lond); 2005 Aug; 109(2):189-97. PubMed ID: 15853770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum paraoxonase-1 activity is more closely related to HDL particle concentration and large HDL particles than to HDL cholesterol in Type 2 diabetic and non-diabetic subjects.
    Dullaart RP; Otvos JD; James RW
    Clin Biochem; 2014 Aug; 47(12):1022-7. PubMed ID: 24769273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased stability of the M54 isoform of paraoxonase as a contributory factor to variations in human serum paraoxonase concentrations.
    Leviev I; Deakin S; James RW
    J Lipid Res; 2001 Apr; 42(4):528-35. PubMed ID: 11290824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum paraoxonase activity, concentration, and phenotype distribution in diabetes mellitus and its relationship to serum lipids and lipoproteins.
    Abbott CA; Mackness MI; Kumar S; Boulton AJ; Durrington PN
    Arterioscler Thromb Vasc Biol; 1995 Nov; 15(11):1812-8. PubMed ID: 7583560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The paraoxonase Leu-Met54 and Gln-Arg191 gene polymorphisms are not associated with the risk of coronary heart disease.
    Gardemann A; Philipp M; Hess K; Katz N; Tillmanns H; Haberbosch W
    Atherosclerosis; 2000 Oct; 152(2):421-31. PubMed ID: 10998471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Paraoxonase gene cluster is a genetic marker for early microvascular complications in type 1 diabetes.
    Kao Y; Donaghue KC; Chan A; Bennetts BH; Knight J; Silink M
    Diabet Med; 2002 Mar; 19(3):212-5. PubMed ID: 11918623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The human paraoxonase Gln-Argl92 (Q/R) polymorphism in turkish patients with coronary artery disease.
    Aynacioglu AS; Kepekci Y
    Int J Cardiol; 2000 Jun; 74(1):33-7. PubMed ID: 10854678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antioxidant potential, paraoxonase 1, ceruloplasmin activity and C-reactive protein concentration in diabetic retinopathy.
    Nowak M; Wielkoszyński T; Marek B; Kos-Kudła B; Swietochowska E; Siemińska L; Karpe J; Kajdaniuk D; Głogowska-Szelag J; Nowak K
    Clin Exp Med; 2010 Sep; 10(3):185-92. PubMed ID: 20012460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.